SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE: Form 990, tax year 2014

View the entire original 990 at ProPublica ↗

Organization: SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (EIN 51-0197108)
Tax period: 2014-07-01 to 2015-06-30
Filed: 2016-05-12
IRS object ID: 201601339349303790
Schema version: 2014v6.0
Source: Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header
Form 990
Schedule A
Schedule B
Schedule C
Schedule D
Schedule F
Schedule G
Schedule J
Schedule K
Schedule L
Schedule O

Return header ReturnHeader

Field	Value	IRS element (for citing)
Return	2016-05-12T12:57:50-05:00	ReturnTs
Tax Period End	2015-06-30	TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

Field	Value	IRS element (for citing)
Business Name Line1	ERNST & YOUNG US LLP	BusinessNameLine1Txt

Preparer US Address PreparerUSAddress

Field	Value	IRS element (for citing)
Address Line1	4370 LA JOLLA VILLAGE DRIVE STE 500	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92122	ZIPCd

Field	Value	IRS element (for citing)
Return Type	990	ReturnTypeCd
Tax Period Begin	2014-07-01	TaxPeriodBeginDt

Filer Filer

Field	Value	IRS element (for citing)
EIN	510197108	EIN

Business Name BusinessName

Field	Value	IRS element (for citing)
Business Name Line1	SANFORD BURNHAM PREBYS MEDICAL DISCOVERY	BusinessNameLine1Txt
Business Name Line2	INSTITUTE	BusinessNameLine2Txt

Field	Value	IRS element (for citing)
In Care Of	% GARY CHESSUM	InCareOfNm
Business Name Control	SANF	BusinessNameControlTxt
Phone	8586463100	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 NORTH TORREY PINES ROAD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Business Officer BusinessOfficerGrp

Field	Value	IRS element (for citing)
Person	GARY RAISL	PersonNm
Person Title	CFO	PersonTitleTxt
Phone	8586463100	PhoneNum
Signature	2016-05-11	SignatureDt
Discuss With Paid Preparer	Yes (true)	DiscussWithPaidPreparerInd

Preparer Person PreparerPersonGrp

Field	Value	IRS element (for citing)
Preparer Person	DEBRA HEISKALA	PreparerPersonNm
PTIN	P00649485	PTIN
Phone	8585357200	PhoneNum

Field	Value	IRS element (for citing)
Tax	2014	TaxYr
Build TS	2016-08-17 19:52:53Z	BuildTS

Form 990 IRS990

Field	Value	IRS element (for citing)
Principal Officer	PERRY NISEN MD PHD	PrincipalOfficerNm

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 NORTH TORREY PINES ROAD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Field	Value	IRS element (for citing)
Gross Receipts	$270,447,270	GrossReceiptsAmt
Group Return For Affiliates	false	GroupReturnForAffiliatesInd
Organization501c3	Yes (X)	Organization501c3Ind
Website Address	WWW.SBPDISCOVERY.ORG	WebsiteAddressTxt
Type Of Organization Corp	Yes (X)	TypeOfOrganizationCorpInd
Formation	1976	FormationYr
Legal Domicile State	CA	LegalDomicileStateCd
Activity Or Mission	SEE SCHEDULE O	ActivityOrMissionDesc
Voting Members Governing Body	22	VotingMembersGoverningBodyCnt
Voting Members Independent	20	VotingMembersIndependentCnt
Total Employee	1000	TotalEmployeeCnt
Total Volunteers	20	TotalVolunteersCnt
Total Gross UBI	$2,400,412	TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm	$160,548	NetUnrelatedBusTxblIncmAmt
PY Contributions Grants	$146,698,221	PYContributionsGrantsAmt
CY Contributions Grants	$244,026,040	CYContributionsGrantsAmt
PY Program Service Revenue	$1,097,834	PYProgramServiceRevenueAmt
CY Program Service Revenue	$906,508	CYProgramServiceRevenueAmt
PY Investment Income	$1,306,528	PYInvestmentIncomeAmt
CY Investment Income	$2,116,377	CYInvestmentIncomeAmt
PY Other Revenue	$4,765,420	PYOtherRevenueAmt
CY Other Revenue	$8,097,885	CYOtherRevenueAmt
PY Total Revenue	$153,868,003	PYTotalRevenueAmt
CY Total Revenue	$255,146,810	CYTotalRevenueAmt
PY Grants And Similar Paid	$0	PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid	$0	CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members	$0	PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members	$0	CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid	$74,256,935	PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid	$77,062,612	CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns	$80,888	PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns	$261,304	CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense	$2,048,182	CYTotalFundraisingExpenseAmt
PY Other Expenses	$68,321,428	PYOtherExpensesAmt
CY Other Expenses	$74,570,051	CYOtherExpensesAmt
PY Total Expenses	$142,659,251	PYTotalExpensesAmt
CY Total Expenses	$151,893,967	CYTotalExpensesAmt
PY Revenues Less Expenses	$11,208,752	PYRevenuesLessExpensesAmt
CY Revenues Less Expenses	$103,252,843	CYRevenuesLessExpensesAmt
Total Assets BOY	$339,669,216	TotalAssetsBOYAmt
Total Assets EOY	$427,646,063	TotalAssetsEOYAmt
Total Liabilities BOY	$107,962,212	TotalLiabilitiesBOYAmt
Total Liabilities EOY	$95,314,852	TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY	$231,707,004	NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY	$332,331,211	NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part III	Yes (X)	InfoInScheduleOPartIIIInd
Mission	SEE SCHEDULE O	MissionDesc
Significant New Program Srvc	false	SignificantNewProgramSrvcInd
Significant Change	false	SignificantChangeInd
Expense	$124,579,982	ExpenseAmt
Grant	$0	GrantAmt
Revenue	$1,531,870	RevenueAmt
Desc	SEE SCHEDULE O	Desc
Total Program Service Expenses	$124,579,982	TotalProgramServiceExpensesAmt
Described In Section501c3	Yes (true)	DescribedInSection501c3Ind
Schedule B Required	Yes (true)	ScheduleBRequiredInd
Political Campaign Acty	false	PoliticalCampaignActyInd
Lobbying Activities	Yes (true)	LobbyingActivitiesInd
Subject To Proxy Tax	false	SubjectToProxyTaxInd
Donor Advised Fund	false	DonorAdvisedFundInd
Conservation Easements	false	ConservationEasementsInd
Collections Of Art	false	CollectionsOfArtInd
Credit Counseling	false	CreditCounselingInd
Temp Or Permanent Endowments	Yes (true)	TempOrPermanentEndowmentsInd
Report Land Building Equipment	Yes (true)	ReportLandBuildingEquipmentInd
Report Investments Other Sec	false	ReportInvestmentsOtherSecInd
Report Program Related Invst	false	ReportProgramRelatedInvstInd
Report Other Assets	false	ReportOtherAssetsInd
Report Other Liabilities	false	ReportOtherLiabilitiesInd
Include FIN48 Footnote	Yes (true)	IncludeFIN48FootnoteInd
Independent Audit Fincl Stmt	Yes (true)	IndependentAuditFinclStmtInd
Consolidated Audit Fincl Stmt	false	ConsolidatedAuditFinclStmtInd
School Operating	false	SchoolOperatingInd
Foreign Office	Yes (true)	ForeignOfficeInd
Foreign Activities	Yes (true)	ForeignActivitiesInd
More Than5000 K To Org	false	MoreThan5000KToOrgInd
More Than5000 K To Individuals	false	MoreThan5000KToIndividualsInd
Professional Fundraising	Yes (true)	ProfessionalFundraisingInd
Fundraising Activities	Yes (true)	FundraisingActivitiesInd
Gaming Activities	false	GamingActivitiesInd
Operate Hospital	false	OperateHospitalInd
Grants To Organizations	false	GrantsToOrganizationsInd
Grants To Individuals	false	GrantsToIndividualsInd
Schedule J Required	Yes (true)	ScheduleJRequiredInd
Tax Exempt Bonds	Yes (true)	TaxExemptBondsInd
Invest Tax Exempt Bonds	false	InvestTaxExemptBondsInd
Escrow Account	false	EscrowAccountInd
On Behalf Of Issuer	false	OnBehalfOfIssuerInd
Engaged In Excess Benefit Trans	false	EngagedInExcessBenefitTransInd
PY Excess Benefit Trans	false	PYExcessBenefitTransInd
Loan Outstanding	Yes (true)	LoanOutstandingInd
Grant To Related Person	false	GrantToRelatedPersonInd
Business Rln With Org Mem	false	BusinessRlnWithOrgMemInd
Business Rln With Fam Mem	Yes (true)	BusinessRlnWithFamMemInd
Business Rln With Officer Ent	false	BusinessRlnWithOfficerEntInd
Deductible Non Cash Contri	false	DeductibleNonCashContriInd
Deductible Art Contribution	false	DeductibleArtContributionInd
Terminate Operations	false	TerminateOperationsInd
Partial Liquidation	false	PartialLiquidationInd
Disregarded Entity	false	DisregardedEntityInd
Related Entity	false	RelatedEntityInd
Related Organization Ctrl Ent	false	RelatedOrganizationCtrlEntInd
Trnsfr Exmpt Non Chrtbl Rltd Org	false	TrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted Prtshp	false	ActivitiesConductedPrtshpInd
Schedule O Required	Yes (true)	ScheduleORequiredInd
IRP Document	243	IRPDocumentCnt
IRP Document W2 G	0	IRPDocumentW2GCnt
Backup Wthld Compliance	Yes (true)	BackupWthldComplianceInd
Employee	1000	EmployeeCnt
Employment Tax Returns Filed	Yes (true)	EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over Limit	Yes (true)	UnrelatedBusIncmOverLimitInd
Form990 T Filed	Yes (true)	Form990TFiledInd
Foreign Financial Account	false	ForeignFinancialAccountInd
Prohibited Tax Shelter Trans	false	ProhibitedTaxShelterTransInd
Taxable Party Notification	false	TaxablePartyNotificationInd
Nondeductible Contributions	false	NondeductibleContributionsInd
Quid Pro Quo Contributions	Yes (true)	QuidProQuoContributionsInd
Quid Pro Quo Contri Discl	Yes (true)	QuidProQuoContriDisclInd
Form8282 Property Disposed Of	false	Form8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft Cntrct	false	RcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft Cntrct	false	PayPremiumsPrsnlBnftCntrctInd
Indoor Tanning Services	false	IndoorTanningServicesInd
Info In Schedule O Part VI	Yes (X)	InfoInScheduleOPartVIInd
Governing Body Voting Members	22	GoverningBodyVotingMembersCnt
Independent Voting Member	20	IndependentVotingMemberCnt
Family Or Business Rln	false	FamilyOrBusinessRlnInd
Delegation Of Mgmt Duties	false	DelegationOfMgmtDutiesInd
Change To Org Documents	Yes (true)	ChangeToOrgDocumentsInd
Material Diversion Or Misuse	false	MaterialDiversionOrMisuseInd
Members Or Stockholders	false	MembersOrStockholdersInd
Election Of Board Members	false	ElectionOfBoardMembersInd
Decisions Subject To Approva	false	DecisionsSubjectToApprovaInd
Minutes Of Governing Body	Yes (true)	MinutesOfGoverningBodyInd
Minutes Of Committees	Yes (true)	MinutesOfCommitteesInd
Officer Mailing Address	false	OfficerMailingAddressInd
Local Chapters	false	LocalChaptersInd
Form990 Provided To Gvrn Body	Yes (true)	Form990ProvidedToGvrnBodyInd
Conflict Of Interest Policy	Yes (true)	ConflictOfInterestPolicyInd
Annual Disclosure Covered Prsn	Yes (true)	AnnualDisclosureCoveredPrsnInd
Regular Monitoring Enfrc	Yes (true)	RegularMonitoringEnfrcInd
Whistleblower Policy	Yes (true)	WhistleblowerPolicyInd
Document Retention Policy	Yes (true)	DocumentRetentionPolicyInd
Compensation Process CEO	Yes (true)	CompensationProcessCEOInd
Compensation Process Other	Yes (true)	CompensationProcessOtherInd
Investment In Joint Venture	false	InvestmentInJointVentureInd
States Where Copy Of Return Is Fld	AL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	AK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	CA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	FL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	IL	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	KY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	ME	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MD	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	MS	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NH	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NJ	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NM	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NY	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	NC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OK	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	OR	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	PA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	RI	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	SC	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	TN	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	UT	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	VA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WA	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WV	StatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is Fld	WI	StatesWhereCopyOfReturnIsFldCd
Upon Request	Yes (X)	UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

Field	Value	IRS element (for citing)
Person	GARY CHESSUM	PersonNm
Phone	8586463100	PhoneNum

US Address USAddress

Field	Value	IRS element (for citing)
Address Line1	10901 N TORREY PINES ROAD	AddressLine1Txt
City	LA JOLLA	CityNm
State Abbreviation	CA	StateAbbreviationCd
ZIP	92037	ZIPCd

Form990 Part VII Section A Form990PartVIISectionAGrp (34 entries)

TitleTitleTxt	Average Hours Per WeekAverageHoursPerWeekRt	Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt	Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd	Reportable Comp From OrgReportableCompFromOrgAmt	Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt	Other CompensationOtherCompensationAmt	OfficerOfficerInd	Highest Compensated EmployeeHighestCompensatedEmployeeInd
DAVID DOWN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
WILLIAM GERHART
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
RASESH THAKKAR
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
LUDER WHITLOCK
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
LORENZO BERHO
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
JAMES BLAIR
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
DANIEL EPSTEIN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
WAINWRIGHT FISHBURN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
PAULINE FOSTER
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
PATRICK GERAGHTY
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
ALAN GLEICHER
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
JEANNE HERBERGER
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
DONALD JERNIGAN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
PAPA DOUG MANCHESTER
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
EDWARD SCHULAK
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
GREG LUCIER
CHAIRMAN	1.0	0.0	Yes (X)	$0	$0	$0	Yes (X)
KRISTIINA VUORI MD PHD
INTERIM CEO/PRESIDENT	50.0	0.0	Yes (X)	$1,124,006	$0	$336,919	Yes (X)
PERRY NISEN MD PHD
CEO	50.0	0.0	Yes (X)	$563,569	$0	$204,422	Yes (X)
HENRY NORDOFF
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
DOUGLAS OBENSHAIN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
BERNARD MACHEN
TRUSTEE	1.0	0.0	Yes (X)	$0	$0	$0
BRENT JACOBS
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
JAMES JARDON
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
PETER PREUSS
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
ANDREW VITERBI
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
ALLEN WEISS
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
GAYLE WILSON
TRUSTEE (PART YEAR)	1.0	0.0	Yes (X)	$0	$0	$0
GARY RAISL ED D
EVP/CAO/CFO/TREASURER	50.0	0.0		$439,576	$0	$42,613	Yes (X)
KNOX BELL
SECRETARY	2.0	0.0		$0	$0	$0	Yes (X)
GARTH POWIS PHD
CENTER DIRECTOR	50.0	0.0		$501,420	$0	$41,055		Yes (X)
DANIEL KELLY MD
CNTR DIR/SCI DIR AT LK NONA	50.0	0.0		$475,364	$0	$47,712		Yes (X)
STUART LIPTON MD PHD
CENTER DIRECTOR	50.0	0.0		$455,233	$0	$50,591		Yes (X)
CARL WARE PHD
CENTER DIRECTOR, IIDC	50.0	0.0		$359,036	$0	$39,136		Yes (X)
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP	50.0	0.0		$354,616	$0	$42,915		Yes (X)

Field	Value	IRS element (for citing)
Total Reportable Comp From Org	$4,272,820	TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org	$0	TotReportableCompRltdOrgAmt
Total Other Compensation	$805,363	TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K	122	IndivRcvdGreaterThan100KCnt
Former Ofcr Employees Listed	false	FormerOfcrEmployeesListedInd
Total Comp Greater Than150 K	Yes (true)	TotalCompGreaterThan150KInd
Compensation From Other Srcs	false	CompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1Txt	CityContractorAddress/USAddress/CityNm	State AbbreviationContractorAddress/USAddress/StateAbbreviationCd	ZIPContractorAddress/USAddress/ZIPCd	ServicesServicesDesc	CompensationCompensationAmt
Deloitte Touche LLP
655 WEST BROADWAY SUITE 700	San Diego	CA	92101	Audit and Consulting	$997,960
Four Oaks Partners Consulting
PO Box 330	Rancho Santa Fe	CA	92067	Consulting-strat pln	$467,749
Dimensional Fund Advisor
1299 Ocean Ave	Santa Monica	CA	90401	Consulting - inv adv	$450,000
Steven K Brauer
2221 Camino del Rio S Suite 300	San Diego	CA	92108	Consulting-Bus. dev.	$445,620
DLA Piper
PO Box 64029	Baltimore	MD	21264	Legal	$277,352

Field	Value	IRS element (for citing)
Cntrct Rcvd Greater Than100 K	5	CntrctRcvdGreaterThan100KCnt
Fundraising	$745,125	FundraisingAmt
Government Grants	$99,616,502	GovernmentGrantsAmt
All Other Contributions	$143,664,413	AllOtherContributionsAmt
Noncash Contributions	$0	NoncashContributionsAmt
Total Contributions	$244,026,040	TotalContributionsAmt

Program Service Revenue ProgramServiceRevenueGrp

Field	Value	IRS element (for citing)
Desc	SHARED SERVICES REVENUE	Desc
Business	541990	BusinessCd
Total Revenue Column	$906,508	TotalRevenueColumnAmt
Related Or Exempt Func Income	$906,508	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$0	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Total Program Service Revenue	$906,508	TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$1,669,596	TotalRevenueColumnAmt
Exclusion	$1,669,596	ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$44,948	TotalRevenueColumnAmt
Exclusion	$44,948	ExclusionAmt

Royalties Revenue RoyaltiesRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$4,892,359	TotalRevenueColumnAmt
Exclusion	$4,892,359	ExclusionAmt

Gross Rents GrossRentsGrp

Field	Value	IRS element (for citing)
Real	$385,488	RealAmt

Rental Income Or Loss RentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Real	$385,488	RealAmt
Personal	$0	PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$385,488	TotalRevenueColumnAmt
Exclusion	$385,488	ExclusionAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

Field	Value	IRS element (for citing)
Securities	$15,463,557	SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

Field	Value	IRS element (for citing)
Securities	$15,061,724	SecuritiesAmt

Gain Or Loss GainOrLossGrp

Field	Value	IRS element (for citing)
Securities	$401,833	SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$401,833	TotalRevenueColumnAmt
Exclusion	$401,833	ExclusionAmt

Field	Value	IRS element (for citing)
Fundraising Gross Income	$33,000	FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event	$745,125	ContriRptFundraisingEventAmt
Fundraising Direct Expenses	$238,736	FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

Field	Value	IRS element (for citing)
Total Revenue Column	-$205,736	TotalRevenueColumnAmt
Exclusion	-$205,736	ExclusionAmt

Net Income From Gaming NetIncomeFromGamingGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Net Income Or Loss NetIncomeOrLossGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$0	TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp (3 entries)

DescDesc	BusinessBusinessCd	Total Revenue ColumnTotalRevenueColumnAmt	Related Or Exempt Func IncomeRelatedOrExemptFuncIncomeAmt	Unrelated Business RevenueUnrelatedBusinessRevenueAmt	ExclusionExclusionAmt
RESEARCH	541700	$2,400,440	$0	$2,400,440	$0
SALE OF REAGENTS	541990	$89,859	$89,859	$0	$0
SYMPOSIUM FEES	541990	$97,500	$97,500	$0	$0

Miscellaneous Revenue MiscellaneousRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$437,975	TotalRevenueColumnAmt
Related Or Exempt Func Income	$438,003	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	-$28	UnrelatedBusinessRevenueAmt
Exclusion	$0	ExclusionAmt

Field	Value	IRS element (for citing)
Other Revenue Total	$3,025,774	OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

Field	Value	IRS element (for citing)
Total Revenue Column	$255,146,810	TotalRevenueColumnAmt
Related Or Exempt Func Income	$1,531,870	RelatedOrExemptFuncIncomeAmt
Unrelated Business Revenue	$2,400,412	UnrelatedBusinessRevenueAmt
Exclusion	$7,188,488	ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

Field	Value	IRS element (for citing)
Total	$3,011,421	TotalAmt
Program Services	$242,400	ProgramServicesAmt
Management And General	$2,769,021	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

Field	Value	IRS element (for citing)
Total	$160,150	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$16,015	ManagementAndGeneralAmt
Fundraising	$144,135	FundraisingAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

Field	Value	IRS element (for citing)
Total	$56,763,016	TotalAmt
Program Services	$48,603,328	ProgramServicesAmt
Management And General	$7,604,718	ManagementAndGeneralAmt
Fundraising	$554,970	FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

Field	Value	IRS element (for citing)
Total	$4,119,003	TotalAmt
Program Services	$3,260,631	ProgramServicesAmt
Management And General	$808,358	ManagementAndGeneralAmt
Fundraising	$50,014	FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

Field	Value	IRS element (for citing)
Total	$9,467,783	TotalAmt
Program Services	$7,946,423	ProgramServicesAmt
Management And General	$1,401,109	ManagementAndGeneralAmt
Fundraising	$120,251	FundraisingAmt

Payroll Taxes PayrollTaxesGrp

Field	Value	IRS element (for citing)
Total	$3,541,239	TotalAmt
Program Services	$2,871,698	ProgramServicesAmt
Management And General	$621,541	ManagementAndGeneralAmt
Fundraising	$48,000	FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

Field	Value	IRS element (for citing)
Total	$2,872,813	TotalAmt
Program Services	$1,010,906	ProgramServicesAmt
Management And General	$1,719,531	ManagementAndGeneralAmt
Fundraising	$142,376	FundraisingAmt

Fees For Services Legal FeesForServicesLegalGrp

Field	Value	IRS element (for citing)
Total	$578,459	TotalAmt
Program Services	$52,191	ProgramServicesAmt
Management And General	$526,268	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Accounting FeesForServicesAccountingGrp

Field	Value	IRS element (for citing)
Total	$352,559	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$352,559	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

Field	Value	IRS element (for citing)
Total	$169,315	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$169,315	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

Field	Value	IRS element (for citing)
Total	$261,304	TotalAmt
Fundraising	$261,304	FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

Field	Value	IRS element (for citing)
Total	$19,456	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$19,456	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Fees For Services Other FeesForServicesOtherGrp

Field	Value	IRS element (for citing)
Total	$1,038,092	TotalAmt
Program Services	$702,987	ProgramServicesAmt
Management And General	$323,512	ManagementAndGeneralAmt
Fundraising	$11,593	FundraisingAmt

Advertising AdvertisingGrp

Field	Value	IRS element (for citing)
Total	$61,739	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$16,701	ManagementAndGeneralAmt
Fundraising	$45,038	FundraisingAmt

Office Expenses OfficeExpensesGrp

Field	Value	IRS element (for citing)
Total	$8,057,300	TotalAmt
Program Services	$7,266,024	ProgramServicesAmt
Management And General	$641,667	ManagementAndGeneralAmt
Fundraising	$149,609	FundraisingAmt

Information Technology InformationTechnologyGrp

Field	Value	IRS element (for citing)
Total	$1,347,846	TotalAmt
Program Services	$1,073,777	ProgramServicesAmt
Management And General	$248,905	ManagementAndGeneralAmt
Fundraising	$25,164	FundraisingAmt

Royalties RoyaltiesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Occupancy OccupancyGrp

Field	Value	IRS element (for citing)
Total	$14,038,551	TotalAmt
Program Services	$12,543,861	ProgramServicesAmt
Management And General	$1,382,227	ManagementAndGeneralAmt
Fundraising	$112,463	FundraisingAmt

Travel TravelGrp

Field	Value	IRS element (for citing)
Total	$678,776	TotalAmt
Program Services	$531,555	ProgramServicesAmt
Management And General	$135,554	ManagementAndGeneralAmt
Fundraising	$11,667	FundraisingAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Conferences Meetings ConferencesMeetingsGrp

Field	Value	IRS element (for citing)
Total	$1,273,430	TotalAmt
Program Services	$920,057	ProgramServicesAmt
Management And General	$325,128	ManagementAndGeneralAmt
Fundraising	$28,245	FundraisingAmt

Interest InterestGrp

Field	Value	IRS element (for citing)
Total	$3,329,574	TotalAmt
Program Services	$3,025,919	ProgramServicesAmt
Management And General	$276,020	ManagementAndGeneralAmt
Fundraising	$27,635	FundraisingAmt

Payments To Affiliates PaymentsToAffiliatesGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$0	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Depreciation Depletion DepreciationDepletionGrp

Field	Value	IRS element (for citing)
Total	$14,811,018	TotalAmt
Program Services	$13,405,174	ProgramServicesAmt
Management And General	$1,311,093	ManagementAndGeneralAmt
Fundraising	$94,751	FundraisingAmt

Insurance InsuranceGrp

Field	Value	IRS element (for citing)
Total	$86,495	TotalAmt
Program Services	$0	ProgramServicesAmt
Management And General	$86,495	ManagementAndGeneralAmt
Fundraising	$0	FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDesc	TotalTotalAmt	Program ServicesProgramServicesAmt	Management And GeneralManagementAndGeneralAmt	FundraisingFundraisingAmt
RESEARCH SUPPLIES & SERV.	$13,598,215	$13,598,215	$0	$0
SCIENTIFIC COLLABORATIONS	$7,178,024	$7,178,024	$0	$0
RECRUITMENT	$522,629	$256,755	$249,619	$16,255
UBI TAXES	$73,866	$0	$73,866	$0

All Other Expenses AllOtherExpensesGrp

Field	Value	IRS element (for citing)
Total	$4,481,894	TotalAmt
Program Services	$90,057	ProgramServicesAmt
Management And General	$4,187,125	ManagementAndGeneralAmt
Fundraising	$204,712	FundraisingAmt

Total Functional Expenses TotalFunctionalExpensesGrp

Field	Value	IRS element (for citing)
Total	$151,893,967	TotalAmt
Program Services	$124,579,982	ProgramServicesAmt
Management And General	$25,265,803	ManagementAndGeneralAmt
Fundraising	$2,048,182	FundraisingAmt

Total Joint Costs TotalJointCostsGrp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

Field	Value	IRS element (for citing)
BOY	$4,983,085	BOYAmt
EOY	$1,340,667	EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

Field	Value	IRS element (for citing)
BOY	$25,616,856	BOYAmt
EOY	$31,300,615	EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$19,526,219	BOYAmt
EOY	$68,063,217	EOYAmt

Accounts Receivable AccountsReceivableGrp

Field	Value	IRS element (for citing)
BOY	$1,614,372	BOYAmt
EOY	$766,396	EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

Field	Value	IRS element (for citing)
BOY	$978,037	BOYAmt
EOY	$1,215,635	EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

Field	Value	IRS element (for citing)
BOY	$5,733,753	BOYAmt
EOY	$6,164,603	EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

Field	Value	IRS element (for citing)
BOY	$175,774	BOYAmt
EOY	$279,777	EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

Field	Value	IRS element (for citing)
BOY	$8,222,046	BOYAmt
EOY	$9,324,340	EOYAmt

Field	Value	IRS element (for citing)
Land Bldg Equip Cost Or Other Bss	$296,845,232	LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec	$157,392,711	LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

Field	Value	IRS element (for citing)
BOY	$147,213,597	BOYAmt
EOY	$139,452,521	EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

Field	Value	IRS element (for citing)
BOY	$122,618,621	BOYAmt
EOY	$166,920,503	EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Intangible Assets IntangibleAssetsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Assets Total OtherAssetsTotalGrp

Field	Value	IRS element (for citing)
BOY	$2,986,856	BOYAmt
EOY	$2,817,789	EOYAmt

Total Assets TotalAssetsGrp

Field	Value	IRS element (for citing)
BOY	$339,669,216	BOYAmt
EOY	$427,646,063	EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

Field	Value	IRS element (for citing)
BOY	$18,358,963	BOYAmt
EOY	$21,187,228	EOYAmt

Grants Payable GrantsPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Deferred Revenue DeferredRevenueGrp

Field	Value	IRS element (for citing)
BOY	$20,329,985	BOYAmt
EOY	$7,053,695	EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$69,273,264	BOYAmt
EOY	$67,073,929	EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Other Liabilities OtherLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$0	BOYAmt
EOY	$0	EOYAmt

Total Liabilities TotalLiabilitiesGrp

Field	Value	IRS element (for citing)
BOY	$107,962,212	BOYAmt
EOY	$95,314,852	EOYAmt

Field	Value	IRS element (for citing)
Organization Follows SFAS117	Yes (X)	OrganizationFollowsSFAS117Ind

Unrestricted Net Assets UnrestrictedNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$84,857,756	BOYAmt
EOY	$138,824,388	EOYAmt

Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$134,816,566	BOYAmt
EOY	$179,491,957	EOYAmt

Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp

Field	Value	IRS element (for citing)
BOY	$12,032,682	BOYAmt
EOY	$14,014,866	EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$231,707,004	BOYAmt
EOY	$332,331,211	EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

Field	Value	IRS element (for citing)
BOY	$339,669,216	BOYAmt
EOY	$427,646,063	EOYAmt

Field	Value	IRS element (for citing)
Info In Schedule O Part XI	Yes (X)	InfoInScheduleOPartXIInd
Reconcilation Revenue Expnss	$103,252,843	ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst	-$2,601,979	NetUnrlzdGainsLossesInvstAmt
Other Changes In Net Assets	-$26,657	OtherChangesInNetAssetsAmt
Method Of Accounting Accrual	Yes (X)	MethodOfAccountingAccrualInd
Accountant Compile Or Review	false	AccountantCompileOrReviewInd
FS Audited	Yes (true)	FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

Field	Value	IRS element (for citing)
Separate Basis Fincl Stmt	Yes (X)	SeparateBasisFinclStmtInd

Field	Value	IRS element (for citing)
Audit Committee	Yes (true)	AuditCommitteeInd
Federal Grant Audit Required	Yes (true)	FederalGrantAuditRequiredInd
Federal Grant Audit Performed	Yes (true)	FederalGrantAuditPerformedInd

Schedule A IRS990ScheduleA

Field	Value	IRS element (for citing)
Public Organization170	Yes (X)	PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$160,093,433	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$156,880,684	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$146,497,371	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$146,698,221	CurrentTaxYearMinus1YearAmt
Current Tax Year	$244,026,040	CurrentTaxYearAmt
Total	$854,195,749	TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$160,093,433	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$156,880,684	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$146,497,371	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$146,698,221	CurrentTaxYearMinus1YearAmt
Current Tax Year	$244,026,040	CurrentTaxYearAmt
Total	$854,195,749	TotalAmt

Field	Value	IRS element (for citing)
Substantial Contributors Tot	$77,967,390	SubstantialContributorsTotAmt
Public Support Total170	$776,228,359	PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus4 Years	$2,037,946	CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years	$4,402,201	CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years	$4,000,400	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$4,044,153	CurrentTaxYearMinus1YearAmt
Current Tax Year	$6,992,391	CurrentTaxYearAmt
Total	$21,477,091	TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

Field	Value	IRS element (for citing)
Current Tax Year Minus2 Years	$144,833	CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year	$195,599	CurrentTaxYearMinus1YearAmt
Current Tax Year	$160,548	CurrentTaxYearAmt
Total	$500,980	TotalAmt

Other Income170 OtherIncome170Grp

Field	Value	IRS element (for citing)
Total	$0	TotalAmt

Field	Value	IRS element (for citing)
Total Support	$876,173,820	TotalSupportAmt
Gross Receipts Rltd Activities	$6,870,575	GrossReceiptsRltdActivitiesAmt
Public Support CY170	0.88593	PublicSupportCY170Pct
Public Support PY170	0.92210	PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170	Yes (X)	ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

Field	Value	IRS element (for citing)
Contributor	RESTRICTED	ContributorNum

Contributor Business Name ContributorBusinessName

Field	Value	IRS element (for citing)
Business Name Line1	RESTRICTED	BusinessNameLine1

Contributor US Address ContributorUSAddress

Field	Value	IRS element (for citing)
Address Line1	RESTRICTED	AddressLine1
Address Line2	RESTRICTED	AddressLine2
City	RESTRICTED	City
State	RESTRICTED	State
ZIP Code	RESTRICTED	ZIPCode

Field	Value	IRS element (for citing)
Total Contributions	RESTRICTED	TotalContributionsAmt

Schedule C IRS990ScheduleC

Field	Value	IRS element (for citing)
Total Grassroots Lobbying		TotalGrassrootsLobbyingGrp
Total Direct Lobbying		TotalDirectLobbyingGrp
Total Lobbying Expend		TotalLobbyingExpendGrp
Other Exempt Purpose Expend		OtherExemptPurposeExpendGrp
Total Exempt Purpose Expend		TotalExemptPurposeExpendGrp
Lobbying Nontaxable Amount		LobbyingNontaxableAmountGrp
Grassroots Nontaxable		GrassrootsNontaxableGrp
Tot Lbbyng Grassroot Mns Non Tx		TotLbbyngGrassrootMnsNonTxGrp
Tot Lbby Expend Mns Lbbyng Non Tx		TotLbbyExpendMnsLbbyngNonTxGrp
Volunteers	false	VolunteersInd
Paid Staff Or Management	false	PaidStaffOrManagementInd
Media Advertisements	false	MediaAdvertisementsInd
Media Advertisements	$0	MediaAdvertisementsAmt
Mailings Members	false	MailingsMembersInd
Mailings Members	$0	MailingsMembersAmt
Publications Or Broadcast	false	PublicationsOrBroadcastInd
Publications Or Broadcast	$0	PublicationsOrBroadcastAmt
Grants Other Organizations	false	GrantsOtherOrganizationsInd
Grants Other Organizations	$0	GrantsOtherOrganizationsAmt
Direct Contact Legislators	Yes (true)	DirectContactLegislatorsInd
Direct Contact Legislators	$86,458	DirectContactLegislatorsAmt
Rallies Demonstrations	false	RalliesDemonstrationsInd
Rallies Demonstrations	$0	RalliesDemonstrationsAmt
Other Activities	Yes (true)	OtherActivitiesInd
Other Activities	$167,733	OtherActivitiesAmt
Total Lobbying Expenditures	$254,191	TotalLobbyingExpendituresAmt
Not Described Section501c3	false	NotDescribedSection501c3Ind

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc

ExplanationExplanationTxt

SCHEDULE C, PART II-B, LINE 1G

LOBBYING ACTIVITIES CONTACT AND MEET WITH FEDERAL AND STATE LEGISLATORS AND THEIR STAFF TO SEEK POTENTIAL RESEARCH FUNDING.

SCHEDULE C, PART II-B, LINE 1I

OTHER ACTIVITIES DUES TO RESEARCH AND BIOMEDICAL ORGANIZATIONS, A PORTION OF WHICH ARE CONSIDERED LOBBYING. THE INSTITUTE UTILIZES ATLANTIC STRATEGIES GROUP, LLC FOR REPRESENTATION IN WASHINGTON DC, TO INVESTIGATE AND SEEK POTENTIAL FEDERAL RESEARCH FUNDING OPPORTUNITIES OUTSIDE THE TRADITIONAL NIH PROCESS. THE INSTITUTE CONTRACTS WITH CAPITAL INSIGHT AND ASSOCIATES FOR REPRESENTATION IN TALLAHASSEE, FL, TO INVESTIGATE AND SEEK POTENTIAL STATE RESEARCH FUNDING OPPORTUNITIES.

Schedule D IRS990ScheduleD

Field	Value	IRS element (for citing)
Art Public Exhibition Amounts		ArtPublicExhibitionAmountsGrp
Held Works Art		HeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$26,870,514	BeginningYearBalanceAmt
Contributions	$920,000	ContributionsAmt
Investment Earnings Or Losses	$36,749	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,133,344	OtherExpendituresAmt
End Year Balance	$26,693,919	EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$22,805,011	BeginningYearBalanceAmt
Contributions	$1,310,000	ContributionsAmt
Investment Earnings Or Losses	$3,778,222	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,022,719	OtherExpendituresAmt
End Year Balance	$26,870,514	EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$21,200,471	BeginningYearBalanceAmt
Contributions	$9,000	ContributionsAmt
Investment Earnings Or Losses	$2,517,312	InvestmentEarningsOrLossesAmt
Other Expenditures	$921,772	OtherExpendituresAmt
End Year Balance	$22,805,011	EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$21,602,848	BeginningYearBalanceAmt
Contributions	$29,575	ContributionsAmt
Investment Earnings Or Losses	$961,439	InvestmentEarningsOrLossesAmt
Other Expenditures	$1,393,391	OtherExpendituresAmt
End Year Balance	$21,200,471	EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

Field	Value	IRS element (for citing)
Beginning Year Balance	$19,352,544	BeginningYearBalanceAmt
Contributions	$1,050,000	ContributionsAmt
Investment Earnings Or Losses	$1,656,322	InvestmentEarningsOrLossesAmt
Other Expenditures	$456,018	OtherExpendituresAmt
End Year Balance	$21,602,848	EndYearBalanceAmt

Field	Value	IRS element (for citing)
Board Designated Balance EOY	0.47640	BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY	0.05460	PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY	0.46900	TermEndowmentBalanceEOYPct
Endowments Held Unrelated Org	false	EndowmentsHeldUnrelatedOrgInd
Endowments Held Related Org	false	EndowmentsHeldRelatedOrgInd

Land LandGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$25,793,087	OtherCostOrOtherBasisAmt
Book Value	$25,793,087	BookValueAmt

Buildings BuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$164,581,234	OtherCostOrOtherBasisAmt
Depreciation	$67,243,740	DepreciationAmt
Book Value	$97,337,494	BookValueAmt

Field	Value	IRS element (for citing)
Leasehold Improvements		LeaseholdImprovementsGrp

Equipment EquipmentGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$106,433,812	OtherCostOrOtherBasisAmt
Depreciation	$90,148,971	DepreciationAmt
Book Value	$16,284,841	BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

Field	Value	IRS element (for citing)
Other Cost Or Other Basis	$37,099	OtherCostOrOtherBasisAmt
Book Value	$37,099	BookValueAmt

Field	Value	IRS element (for citing)
Total Book Value Land Buildings	$139,452,521	TotalBookValueLandBuildingsAmt
Federal Income Tax Liability	$0	FederalIncomeTaxLiabilityAmt
Total Liability	$0	TotalLiabilityAmt
Footnote Text	Yes (X)	FootnoteTextInd
Total Rev Etc Audited Fincl Stmt	$252,525,000	TotalRevEtcAuditedFinclStmtAmt
Net Unrealized Gains Invst	-$2,601,979	NetUnrealizedGainsInvstAmt
Other Revenue	-$375	OtherRevenueAmt
Revenue Not Reported	-$2,602,354	RevenueNotReportedAmt
Revenue Subtotal	$255,127,354	RevenueSubtotalAmt
Investment Expenses Not Incld	$19,456	InvestmentExpensesNotIncldAmt
Revenue Not Reported Fincl Stmt	$19,456	RevenueNotReportedFinclStmtAmt
Total Revenue Per Form990	$255,146,810	TotalRevenuePerForm990Amt
Tot Expns Etc Audited Fincl Stmt	$151,902,000	TotExpnsEtcAuditedFinclStmtAmt
Other Expenses Included	$26,659	OtherExpensesIncludedAmt
Expenses Not Reported	$26,659	ExpensesNotReportedAmt
Expenses Subtotal	$151,875,341	ExpensesSubtotalAmt
Investment Expenses Not Incld2	$19,456	InvestmentExpensesNotIncld2Amt
Other Expenses Not Included	-$830	OtherExpensesNotIncludedAmt
Expenses Not Rpt Fincl Stmt	$18,626	ExpensesNotRptFinclStmtAmt
Total Expenses Per Form990	$151,893,967	TotalExpensesPerForm990Amt

Supplemental Information Detail SupplementalInformationDetail (5 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE D, PART V, LINE 4	INTENDED USES OF THE ORGANIZATION'S ENDOWMENT FUNDS THE INSTITUTE'S ENDOWMENT FUNDS ARE ESTABLISHED FOR VARIOUS PURPOSES: SCIENTIFIC RESEARCH, ALS RESEARCH, CEO CHAIR, PRESIDENTIAL CHAIR, LEADERSHIP CHAIR IN CANCER RESEARCH, AND UNRESTRICTED AS TO INCOME.
SCHEDULE D, PART X, LINE 2	FIN 48 (ASC 740) FOOTNOTE THE INSTITUTE HAS NO MATERIAL DEFERRED TAX ASSETS OR DEFERRED TAX LIABILITIES RECORDED AS OF JUNE 30, 2015 AND 2014. THE INSTITUTE DID NOT RECOGNIZE A CHANGE IN LIABILITY FOR UNRECOGNIZED TAX BENEFITS (THE DIFFERENCE BETWEEN A TAX POSITION TAKEN, OR EXPECTED TO BE TAKEN, IN A TAX RETURN AND THE BENEFIT RECOGNIZED AND MEASURED IN THE FINANCIAL STATEMENTS). THE INSTITUTE'S LIABILITY FOR UNRECOGNIZED TAX BENEFITS WAS $0 AT JUNE 30, 2015 AND 2014.
SCHEDULE D, PART XI, LINE 2D	ROUNDING - (375)
SCHEDULE D, PART XII, LINE 2D	unrealized loss on swap - 26,659
SCHEDULE D, PART XII, LINE 4D	ROUNDING - (830)

Schedule F IRS990ScheduleF

Account Activities Outside US AccountActivitiesOutsideUSGrp (8 entries)

RegionRegionTxt	EmployeeEmployeeCnt	Type Of Activities ConductedTypeOfActivitiesConductedTxt	Specific Services ProvidedSpecificServicesProvidedTxt	Region Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)	63	Program services	See Part V	$168,464
East Asia and the Pacific	18	Program services	See Part V	$24,624
North America	1	Program services	See Part V	$500
South Asia	6	Program services	See Part V	$8,983
Middle East and North Africa	5	Program services	See Part V	$1,118
Russia and the Newly Independent States	1	Program services	See Part V	$143
South America	4	Program services	See Part V	$11,074
Central America and the Caribbean	2	Program services	See Part V	$478

Field	Value	IRS element (for citing)
Subtotal Employees	100	SubtotalEmployeesCnt
Total Employee	100	TotalEmployeeCnt
Subtotal Spent	$215,384	SubtotalSpentAmt
Total Spent	$215,384	TotalSpentAmt
Transfer To Foreign Corp	false	TransferToForeignCorpInd
Interest In Foreign Trust	false	InterestInForeignTrustInd
Foreign Corp Ownership	false	ForeignCorpOwnershipInd
Passive Foreign Investmest Co	false	PassiveForeignInvestmestCoInd
Foreign Partnership	false	ForeignPartnershipInd
Boycott Countries	false	BoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail (3 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE F, PART I, LINE 3	Procedures for Monitoring Use of Grants Sanford Burnham Prebys Medical Discovery Institute does not maintain ongoing operations in foreign jurisdictions. However, the Institute's scientist do travel to various scientific conferences in other countries to share the Institute's scientific discoveries, as well as, to learn from other scientists across the world.
Schedule F, Part I, Line 3, Column E	Type of Service Specific Program Service Activity in all regions is agents attending and/or speaking at scientific conferences and collaborations.
SCHEDULE F, PART I, LINE 3, COLUMN E	Accounting Method The accrual method of accounting was used to determine the amounts in Part I, line 3, column F.

Schedule G IRS990ScheduleG

Field	Value	IRS element (for citing)
Mail Solicitations	Yes (X)	MailSolicitationsInd
Email Solicitations	Yes (X)	EmailSolicitationsInd
Phone Solicitations	Yes (X)	PhoneSolicitationsInd
In Person Solicitations	Yes (X)	InPersonSolicitationsInd
Solicitation Of Non Govt Grants	Yes (X)	SolicitationOfNonGovtGrantsInd
Solicitation Of Govt Grants	Yes (X)	SolicitationOfGovtGrantsInd
Special Fundraising Events	Yes (X)	SpecialFundraisingEventsInd
Agrmt Prof Fundraising Acty	Yes (true)	AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp (2 entries)

Address Line1USAddress/AddressLine1Txt	CityUSAddress/CityNm	State AbbreviationUSAddress/StateAbbreviationCd	ZIPUSAddress/ZIPCd	ActivityActivityTxt	Fundraiser Control Of FundsFundraiserControlOfFundsInd	Retained By ContractorRetainedByContractorAmt
ED GILLENWATERS
3307 A VENIDA ANACAPA	CARLSBAD	CA	92009	CONSULTING	false	$255,004
BLAIR BLUM PARTNERS
2504 EVERGREEN STREET	SAN DIEGO	CA	92106	CONSULTING	false	$6,300

Field	Value	IRS element (for citing)
Total Retained By Contractors	$261,304	TotalRetainedByContractorsAmt
Licensed States	AL	LicensedStatesCd
Licensed States	AK	LicensedStatesCd
Licensed States	AZ	LicensedStatesCd
Licensed States	AR	LicensedStatesCd
Licensed States	CA	LicensedStatesCd
Licensed States	CT	LicensedStatesCd
Licensed States	FL	LicensedStatesCd
Licensed States	ID	LicensedStatesCd
Licensed States	IL	LicensedStatesCd
Licensed States	IN	LicensedStatesCd
Licensed States	IA	LicensedStatesCd
Licensed States	KS	LicensedStatesCd
Licensed States	KY	LicensedStatesCd
Licensed States	LA	LicensedStatesCd
Licensed States	ME	LicensedStatesCd
Licensed States	MD	LicensedStatesCd
Licensed States	MA	LicensedStatesCd
Licensed States	MI	LicensedStatesCd
Licensed States	MS	LicensedStatesCd
Licensed States	MO	LicensedStatesCd
Licensed States	MT	LicensedStatesCd
Licensed States	NE	LicensedStatesCd
Licensed States	NV	LicensedStatesCd
Licensed States	NH	LicensedStatesCd
Licensed States	NJ	LicensedStatesCd
Licensed States	NM	LicensedStatesCd
Licensed States	NY	LicensedStatesCd
Licensed States	NC	LicensedStatesCd
Licensed States	ND	LicensedStatesCd
Licensed States	OH	LicensedStatesCd
Licensed States	OK	LicensedStatesCd
Licensed States	OR	LicensedStatesCd
Licensed States	PA	LicensedStatesCd
Licensed States	RI	LicensedStatesCd
Licensed States	SC	LicensedStatesCd
Licensed States	SD	LicensedStatesCd
Licensed States	TN	LicensedStatesCd
Licensed States	TX	LicensedStatesCd
Licensed States	UT	LicensedStatesCd
Licensed States	VT	LicensedStatesCd
Licensed States	VA	LicensedStatesCd
Licensed States	WA	LicensedStatesCd
Licensed States	WV	LicensedStatesCd
Licensed States	WI	LicensedStatesCd
Licensed States	WY	LicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

Field	Value	IRS element (for citing)
Event1	GALA	Event1Nm
Gross Receipts Event1	$778,125	GrossReceiptsEvent1Amt
Charitable Contri Event1	$745,125	CharitableContriEvent1Amt
Gross Revenue Event1	$33,000	GrossRevenueEvent1Amt
Food And Beverage Event1	$68,549	FoodAndBeverageEvent1Amt
Entertainment Event1	$132,803	EntertainmentEvent1Amt
Other Direct Expenses Event1	$37,384	OtherDirectExpensesEvent1Amt
Other Events Total	0	OtherEventsTotalCnt
Gross Receipts Total	$778,125	GrossReceiptsTotalAmt
Charitable Contributions Tot	$745,125	CharitableContributionsTotAmt
Gross Revenue Total Events	$33,000	GrossRevenueTotalEventsAmt
Food And Beverage Total Events	$68,549	FoodAndBeverageTotalEventsAmt
Entertainment Total Events	$132,803	EntertainmentTotalEventsAmt
Oth Direct Expnss Total Events	$37,384	OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events	$238,736	DirectExpenseSummaryEventsAmt
Net Income Summary	-$205,736	NetIncomeSummaryAmt

Schedule J IRS990ScheduleJ

Field	Value	IRS element (for citing)
First Class Or Charter Travel	Yes (X)	FirstClassOrCharterTravelInd
Club Dues Or Fees	Yes (X)	ClubDuesOrFeesInd
Written Policy Ref T And E Expnss	Yes (true)	WrittenPolicyRefTAndEExpnssInd
Substantiation Required	Yes (true)	SubstantiationRequiredInd
Compensation Committee	Yes (X)	CompensationCommitteeInd
Independent Consultant	Yes (X)	IndependentConsultantInd
Form990 Of Other Organizations	Yes (X)	Form990OfOtherOrganizationsInd
Written Employment Contract	Yes (X)	WrittenEmploymentContractInd
Compensation Survey	Yes (X)	CompensationSurveyInd
Board Or Committee Approval	Yes (X)	BoardOrCommitteeApprovalInd
Severance Payment	false	SeverancePaymentInd
Supplemental Nonqual Rtr Plan	Yes (true)	SupplementalNonqualRtrPlanInd
Equity Based Comp Arrngm	false	EquityBasedCompArrngmInd
Comp Based On Revenue Of Flng Org	false	CompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related Orgs	false	CompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng Org	false	CompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd Orgs	false	CompBsdNetEarnsRltdOrgsInd
Any Non Fixed Payments	Yes (true)	AnyNonFixedPaymentsInd
Initial Contract Exception	false	InitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (8 entries)

TitleTitleTxt	Base Compensation Filing OrgBaseCompensationFilingOrgAmt	Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt	Bonus Filing OrganizationBonusFilingOrganizationAmount	Bonus Related OrganizationsBonusRelatedOrganizationsAmt	Other Compensation Filing OrgOtherCompensationFilingOrgAmt	Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt	Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt	Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt	Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt	Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt	Total Compensation Filing OrgTotalCompensationFilingOrgAmt	Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt	Comp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmt	Comp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
KRISTIINA VUORI MD PHD
INTERIM CEO/PRESIDENT	$622,505	$0	$500,000	$0	$1,501	$0	$326,000	$0	$10,919	$0	$1,460,925	$0	$0	$0
PERRY NISEN MD PHD
CEO	$237,817	$0	$325,000	$0	$752	$0	$200,000	$0	$4,422	$0	$767,991	$0	$0	$0
GARY RAISL ED D
EVP/CAO/CFO/TREASURER	$435,062	$0	$0	$0	$4,514	$0	$26,000	$0	$16,613	$0	$482,189	$0	$0	$0
GARTH POWIS PHD
CENTER DIRECTOR	$446,133	$0	$50,000	$0	$5,287	$0	$26,000	$0	$15,055	$0	$542,475	$0	$0	$0
DANIEL KELLY MD
CNTR DIR/SCI DIR AT LK NONA	$472,409	$0	$0	$0	$2,955	$0	$26,000	$0	$21,712	$0	$523,076	$0	$0	$0
STUART LIPTON MD PHD
CENTER DIRECTOR	$451,040	$0	$0	$0	$4,193	$0	$26,000	$0	$24,591	$0	$505,824	$0	$0	$0
CARL WARE PHD
CENTER DIRECTOR, IIDC	$354,666	$0	$0	$0	$4,370	$0	$26,000	$0	$13,136	$0	$398,172	$0	$0	$0
MICHAEL JACKSON PHD
DRUG DISCOVERY & DEV, SR VP	$352,606	$0	$0	$0	$2,010	$0	$26,000	$0	$16,915	$0	$397,531	$0	$0	$0

Supplemental Information Detail SupplementalInformationDetail (4 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, SCHEDULE J, PART I, LINE 1A	FIRST CLASS TRAVEL FIRST CLASS TRAVEL IS GENERALLY NOT PERMITTED, EXCEPT UNDER VERY LIMITED AND RARE CIRCUMSTANCES AND CONDITIONS, SUCH AS A MEDICAL CONDITION REQUIREMENT AND URGENT CIRCUMSTANCES. THIS WAS NOT TREATED AS TAXABLE COMPENSATION. HEALTH OR SOCIAL CLUB DUES HEALTH OR SOCIAL CLUB DUES ARE NEGOTIATED IN THE HIRING PROCESS FOR CERTAIN EMPLOYEES. THE AMOUNTS WERE TREATED AS TAXABLE COMPENSATION.
FORM 990, SCHEDULE J, PART I, LINE 4B	SUPPLEMENTAL NONQUALIFIED RETIREMENT PLAN THE PARTICIPANTS OF THE 457(F) DEFERRED COMPENSATION PLAN ARE KRISTIINA VUORI AND PERRY NISEN. VESTING FOR KRISTIINA VUORI OCCURS THE EARLIEST OF 4/1/2015 & PERRY NISEN THE EARLIEST OF 9/15/19, OR INVOLUNTARY TERMINATION WITHOUT CAUSE, OR PARTICIPANT'S RESIGNATION FOR GOOD CAUSE, OR THE DATE OF TERMINATION OF THE PLAN. DISTRIBUTION IS A ONE-TIME LUMP SUM PAYMENT UPON VESTING OF 100% OF THE VALUE OF THE PARTICIPANT'S INVESTMENT (COMPRISED OF INSTITUTE CONTRIBUTIONS TO THE CORPUS PLUS ANY INVESTMENT GAINS OR LOSSES THEREON).
FORM 990, SCHEDULE J, PART I, LINE 7	NON-FIXED PAYMENTS SOME SENIOR EXECUTIVES HAVE EMPLOYMENT AGREEMENTS STIPULATING A BONUS WILL BE PAID TO THEM PROVIDED CERTAIN GOALS OR ACCOMPLISHMENTS ARE ACHIEVED.
FORM 990, SCHEDULE J, PART II, COLUMN C	RETIREMENT AND OTHER DEFERRED COMPENSATION THE AMOUNT REPORTED IN SCHEDULE J, PART II, COLUMN C FOR KRISTIINA VUORI AND PERRY NISEN INCLUDES AN ACCRUAL OF $300,000 AND $200,000 RESPECTIVELY RELATED TO THE 457(F) PLAN DESCRIBED ABOVE. THESE AMOUNTS ARE NOT VESTED AND ARE SUBJECT TO SUBSTANTIAL RISK OF FORFEITURE.

Schedule K IRS990ScheduleK

Tax Exempt Bonds Issues TaxExemptBondsIssuesGrp (2 entries)

Bond ReferenceBondReferenceCd	Bond Issuer EINBondIssuerEIN	CUSIPCUSIPNum	Bond IssuedBondIssuedDt	Issue PriceIssuePriceAmt	PurposePurposeDesc	DefeasedDefeasedInd	On Behalf Of IssuerOnBehalfOfIssuerInd	Pool FinancingPoolFinancingInd
COUNTY OF SAN DIEGO
A	956000934	797391G60	2006-02-01	$60,572,867	SEE PART VI	false	false	false
COUNTY OF SAN DIEGO
B	956000934	797391K99	2012-11-15	$18,885,000	FINANCE PROPERTY AND CAPITAL EQUIP	false	false	false

Tax Exempt Bonds Proceeds TaxExemptBondsProceedsGrp (2 entries)

Bond ReferenceBondReferenceCd	RetiredRetiredAmt	Bond DefeasedBondDefeasedAmt	Total ProceedsTotalProceedsAmt	In Reserve FundInReserveFundAmt	Capitalized InterestCapitalizedInterestAmt	Refunding EscrowRefundingEscrowAmt	Issuance Costs From ProceedsIssuanceCostsFromProceedsAmt	Credit EnhancementCreditEnhancementAmt	Working Capital ExpendituresWorkingCapitalExpendituresAmt	Capital ExpendituresCapitalExpendituresAmt	Other Spent ProceedsOtherSpentProceedsAmt	UnspentUnspentAmt	Substantial CompletionSubstantialCompletionYr	Current RefundingCurrentRefundingInd	Advance RefundingAdvanceRefundingInd	Final Allocation MadeFinalAllocationMadeInd	Adequate Books And Rec MaintAdequateBooksAndRecMaintInd
A	$0	$0	$60,572,867	$3,958,500	$0	$46,326,377	$745,537	$0	$0	$9,542,453	$0	$0	2000	false	Yes (true)	Yes (true)	Yes (true)
B	$0	$0	$18,885,000	$0	$0	$0	$0	$0	$0	$18,885,000	$0	$0	2012	false	false	Yes (true)	Yes (true)

Tax Exempt Bonds Private Bus Use TaxExemptBondsPrivateBusUseGrp (2 entries)

Bond ReferenceBondReferenceCd	Owning Bond Financed PropertyOwningBondFinancedPropertyInd	Any Lease ArrangementsAnyLeaseArrangementsInd	Mgmt Contract Bond Fincd PropMgmtContractBondFincdPropInd	Engage Bond Counsel ContractsEngageBondCounselContractsInd	Any Research AgreementsAnyResearchAgreementsInd	Engage Bond Counsel ResearchEngageBondCounselResearchInd	Private Bus Use By OthersPrivateBusUseByOthersPct	Private Bus Concerning UBIPrivateBusConcerningUBIPct	Total Private Business UseTotalPrivateBusinessUsePct	Bond Iss Meet Prvt Sec Pymt TestBondIssMeetPrvtSecPymtTestInd	Change In Use Bond Financed PropChangeInUseBondFinancedPropInd	Remedial Action TakenRemedialActionTakenInd	Procs Nonqualified Bond RemdtdProcsNonqualifiedBondRemdtdInd
A	false	Yes (true)	Yes (true)	Yes (true)	Yes (true)	Yes (true)	0.03410	0.00000	0.03410	false	false	false	false
B	false	false	false		false		0.01980		0.01980	false	false	false	false

Tax Exempt Bonds Arbitrage TaxExemptBondsArbitrageGrp (2 entries)

Bond ReferenceBondReferenceCd	Form8038 T FiledForm8038TFiledInd	Variable Rate IssueVariableRateIssueInd	Hedge Identified In Bks And RecHedgeIdentifiedInBksAndRecInd	Gross Proceeds Invested In GICGrossProceedsInvestedInGICInd	Business Name Line1GICProviderName/BusinessNameLine1Txt	Gross Proceeds InvestedGrossProceedsInvestedInd	Written Proc To Monitor ReqsWrittenProcToMonitorReqsInd	Rebate Not Due YetRebateNotDueYetInd	Exception To RebateExceptionToRebateInd	Term Of HedgeTermOfHedgePct	Superintegrated HedgeSuperintegratedHedgeInd	Hedge TerminatedHedgeTerminatedInd
0
A	Yes (true)	false	false	false	0	false	false
BANK OF AMERICA
B	false	Yes (true)	Yes (true)	false	0	false	false	Yes (true)	false	25.	Yes (true)	false

Procedures Corrective Action ProceduresCorrectiveActionGrp (2 entries)

Bond ReferenceBondReferenceCd	Procedures Corrective ActionProceduresCorrectiveActionInd
A	false
B	Yes (true)

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
SCHEDULE K, PART I, ROW A, COLUMN (F)	REFINANCE 1999 BONDS WITH ISSUE DATE 09/14/1999 AND FINANCE CAPITAL IMPROVEMENTS & EQUIPMENT.
SCHEDULE K, PART I, ROWS A-C	FOR THE BOND ISSUES LISTED IN PART I, THE ALTERNATIVE PERIOD USED FOR THE REPORTING REQUIREMENTS IN THIS SECTION IS THE TWELVE MONTHS ENDED DECEMBER 31, 2014.

Schedule L IRS990ScheduleL

Loans Btwn Org Interested Prsn LoansBtwnOrgInterestedPrsnGrp (2 entries)

Relationship With OrgRelationshipWithOrgTxt	Loan PurposeLoanPurposeTxt	Loan From OrganizationLoanFromOrganizationInd	Original PrincipalOriginalPrincipalAmt	Balance DueBalanceDueAmt	DefaultDefaultInd	Board Or Committee ApprovalBoardOrCommitteeApprovalInd	Written AgreementWrittenAgreementInd
GARY RAISL
OFFICER	QUAL. EMPLOYEE RELOC	Yes (X)	$225,000	$215,635	false	Yes (true)	Yes (true)
PERRY NISEN
OFFICER	QUAL. EMPLOYEE RELOC	Yes (X)	$1,000,000	$1,000,000	false	Yes (true)	Yes (true)

Field	Value	IRS element (for citing)
Total Balance Due	$1,215,635	TotalBalanceDueAmt

Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp

Name Of Interested NameOfInterested

Field	Value	IRS element (for citing)
Person	PHILIP GRAHAM	PersonNm

Field	Value	IRS element (for citing)
Relationship Description	GAYLE WILSON - TRUSTEE	RelationshipDescriptionTxt
Transaction	$160,150	TransactionAmt
Transaction	COMPENSATION	TransactionDesc
Sharing Of Revenues	false	SharingOfRevenuesInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (7 entries)

Form And Line ReferenceFormAndLineReferenceDesc	ExplanationExplanationTxt
FORM 990, PART I, LINE 1 & PART III, LINE 1	ORGANIZATION'S MISSION SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE CONDUCTS WORLD-CLASS, COLLABORATIVE RESEARCH DEDICATED TO FINDING CURES FOR HUMAN DISEASE, IMPROVING THE QUALITY OF LIFE, AND THUS CREATING A LEGACY FOR ITS EMPLOYEES, PARTNERS, DONORS, AND COMMUNITY.
FORM 990, PART III, LINE 4	PROGRAM SERVICE ACCOMPLISHMENTS SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE (SBP) IS DEDICATED TO DISCOVERING THE FUNDAMENTAL MOLECULAR CAUSES OF DISEASE AND DEVISING INNOVATIVE THERAPIES OF TOMORROW. SBP TAKES A UNIQUE, COLLABORATIVE APPROACH TO MEDICAL RESEARCH AND HAS ESTABLISHED MAJOR RESEARCH PROGRAMS IN CANCER, NEURODEGENERATION, DIABETES, AND INFECTIOUS, INFLAMMATORY, AND CHILDHOOD DISEASES. CANCER PROMISING NEW MELANOMA DRUG. MELANOMA IS THE DEADLIEST FORM OF SKIN CANCER; 9,000 PEOPLE IN THE U.S. DIE FROM THE DISEASE EACH YEAR. ABOUT 50% OF MELANOMAS ARE CAUSED BY MUTATIONS IN A SPECIFIC GENE CALLED BRAF. PATIENTS WITH THESE TUMORS ARE COMMONLY PRESCRIBED VEMURAFENIB, A BRAF INHIBITOR THAT SHRINKS TUMORS. HOWEVER, MANY PATIENTS' CANCER REAPPEARS BECAUSE TUMORS EVOLVE AND BECOME RESISTANT TO THE DRUG. A RESEARCH TEAM LED BY ZE'EV RONAI SHOWED IN A CANCER RESEARCH PAPER THAT CO-ADMINISTERING A NEW COMPOUND WITH VEMURAFENIB ELIMINATES MELANOMAS AND PREVENTS THEIR REOCCURRENCE. THE COMPOUND BLOCKS THE COMPLEX THAT INITIATES PROTEIN SYNTHESIS, WHICH IS REQUIRED FOR TUMOR CELL GROWTH AND PROLIFERATION. THE NEXT GENERATION OF THE COMPOUND SHOULD BE READY FOR CLINICAL TRIALS, POSSIBLY YIELDING A NEW TREATMENT FOR MELANOMA WITHIN TEN YEARS. ENHANCING DRUG DELIVERY TO TUMORS. A MAJOR CHALLENGE IN TREATING CANCER IS DELIVERING SUFFICIENT AMOUNTS OF DRUG TO THE INTENDED TARGET. OFTEN, CANCER DRUGS DO NOT PENETRATE THE TUMOR BUT INSTEAD HIT CELLS NEAR BLOOD VESSELS. ERKKI RUOSLAHTI'S TEAM THEREFORE SOUGHT MOLECULES THAT DO A BETTER JOB AT PENETRATING TUMORS, WHICH COULD BE ATTACHED TO DRUG-LOADED NANOPARTICLES TO DELIVER LARGE QUANTITIES OF CANCER DRUG. YEARS AGO, BY INJECTING A LIBRARY OF DIFFERENT PROTEIN FRAGMENTS (CALLED PEPTIDES) INTO MICE WITH CANCER, AND ASSESSING WHICH PENETRATED THE TUMOR MOST EFFECTIVELY, THEY FOUND SUCH A PEPTIDE. THIS YEAR, IN WORK PUBLISHED IN SCIENCE ADVANCES, THEY DETERMINED HOW IT TARGETS CANCER CELLS. THE PEPTIDE ACTIVATES A PATHWAY THAT NORMALLY FUNCTIONS TO INCREASE NUTRIENT UPTAKE INTO TUMOR CELLS, INSTEAD CAUSING THEM TO TAKE UP DRUG-LOADED NANOPARTICLES. THE PEPTIDE IS UNDERGOING PRECLINICAL DEVELOPMENT, AND COULD BE USED IN FUTURE NANOPARTICLE-BASED CANCER THERAPIES. NEW DRUG SQUASHES CANCER'S LAST-DITCH EFFORTS TO SURVIVE. CANCER CELLS REQUIRE MORE ENERGY THAN NORMAL CELLS, AND OFTEN PROLIFERATE FASTER THAN THE BLOOD VESSEL NETWORK SUPPLYING NUTRIENTS, SO THEY RELY ON UNUSUAL MECHANISMS TO GENERATE THEM. ONE SUCH MECHANISM IS AUTOPHAGY, THE RECYCLING OF WORN-OUT CELL COMPARTMENTS. FURTHER, CERTAIN CANCER DRUGS, SUCH AS RAPAMYCIN, LEAD TO ACTIVATION OF AUTOPHAGY BY BLOCKING THE PATHWAYS THAT NORMALLY SUPPORT CELL GROWTH. THUS, SPECIFIC INHIBITORS OF AUTOPHAGY ARE HIGHLY SOUGHT AFTER AS COMPLEMENTS TO THESE CHEMOTHERAPIES. NICK COSFORD'S LAB WORKED WITH A LAB AT THE SALK INSTITUTE TO SCREEN CANDIDATES THEY HAD DEVELOPED BASED ON THE CHEMISTRY OF AN ENZYME THAT KICKS OFF THE PROCESS, CALLED ULK1. IN MOLECULAR CELL, THEY PUBLISHED EVIDENCE THAT ONE COMPOUND INHIBITS ULK1 NOT JUST IN A TEST TUBE BUT ALSO IN NUMEROUS TYPES OF TUMOR CELLS. THE TEAM IS NOW TESTING THE DRUG IN PRECLINICAL CANCER MODELS; IF PROVEN EFFECTIVE, IT WOULD MOVE FORWARD INTO HUMAN TRIALS. NEW STUDY SHEDS LIGHT ON CANCER STEM CELL REGULATION. COLON CANCER RESULTS FROM MISREGULATION OF PROLIFERATION AND DNA REPAIR IN INTESTINAL STEM CELLS, WHICH REPOPULATE THE INTESTINAL LINING EVERY THREE TO FIVE DAYS. IN A RECENT PAPER PUBLISHED IN CELL REPORTS, JORGE MOSCAT AND MARIA DIAZ-MECO DELINEATE THE PRECISE MECHANISM BY WHICH ONE TYPE OF STEM CELL MISREGULATION LEADS TO OVERPROLIFERATION. THEY HAD PREVIOUSLY SHOWN THAT A PARTICULAR SIGNALING ENZYME, PKC-ZETA, IS PRESENT AT VERY LOW LEVELS IN COLON CANCER AND FUNCTIONS TO PREVENT TUMOR PROGRESSION. HERE, THEY SHOWED THAT THIS OCCURS BY DIRECT MODIFICATION OF TWO MOLECULES WHOSE ACTIVITY PROMOTES CANCER, BETA-CATENIN AND YAP; THESE MODIFICATIONS PROMOTE DEGRADATION OF THE TWO PROTEINS. THOUGH THE PRO-CANCER FUNCTIONS OF BETA-CATENIN AND YAP ARE ALREADY WELL KNOWN, THESE FINDINGS INDICATE THAT PKC-ZETA-DEFICIENT COLON CANCERS SHOULD BE TREATED WITH INHIBITORS OF BETA-CATENIN AND YAP. A BETA-CATENIN INHIBITOR IS CURRENTLY IN CLINICAL TRIALS FOR COLON CANCER. DEGENERATIVE DISEASE ANTIOXIDANT-RICH DIET COULD HELP STAVE OFF TYPE 2 DIABETES. TYPE 2 DIABETES RESULTS FROM THE FAILURE OF BETA CELLS IN THE PANCREAS TO PRODUCE SUFFICIENT INSULIN TO MAINTAIN NORMAL GLUCOSE LEVELS. IN THIS CONDITION, BETA CELLS FAIL BECAUSE OF THE INCREASED DEMAND FOR INSULIN (RESULTING FROM INSULIN RESISTANCE AND HIGH BLOOD GLUCOSE). BETA CELLS TRY TO COMPENSATE BY PRODUCING UP TO 10 TIMES THE USUAL AMOUNT OF INSULIN, BUT THIS PUTS EXTRA STRESS ON A CELL STRUCTURE CALLED THE ENDOPLASMIC RETICULUM (ER) TO PROPERLY FOLD, PROCESS, AND SECRETE THE HORMONE. AS THE RESPONSE TO ER STRESS INVOLVES A PROTEIN CALLED IRE1-ALPHA, RANDAL KAUFMAN'S LAB SPECIFICALLY INACTIVATED THE IRE1-ALPHA GENE IN BETA CELLS TO EXAMINE HOW ER STRESS BLOCKS INSULIN PRODUCTION. IN A PAPER IN PLOS BIOLOGY, THEY SHOW THAT THIS GENETIC ALTERATION IMPAIRS EXPRESSION OF MANY GENES INVOLVED IN EXPANDING CELLS' CAPACITY TO SECRETE PROTEINS. FURTHER, THEY OBSERVED THAT IT INCREASES EXPRESSION OF GENES THAT CAUSE OR EXACERBATE OXIDATIVE STRESS (INCREASED LEVELS OF MOLECULES THAT DAMAGE CELL COMPONENTS BY OXIDATION). IN LIGHT OF THAT FINDING, THEY GAVE THE ANIMALS ANTIOXIDANT-CONTAINING FOOD, WHICH INCREASED INSULIN PRODUCTION SUFFICIENTLY TO AMELIORATE THEIR HYPERGLYCEMIA. THESE RESULTS SUGGEST THAT DIETARY ANTIOXIDANTS COULD HELP REDUCE THE SEVERITY OF TYPE 2 DIABETES. HOW PROTEIN TANGLES ACCUMULATE IN THE BRAIN AND CAUSE NEUROLOGICAL DISORDERS. MULTIPLE AGE-RELATED NEURODEGENERATIVE DISORDERS, INCLUDING ALZHEIMER'S AND PROGRESSIVE SUPRANUCLEAR PALSY (PSP), INVOLVE ACCUMULATION OF TANGLES OF AGGREGATED TAU PROTEIN. UNDERSTANDING HOW THESE TANGLES ARE FORMED MAY POINT TO WAYS TO PREVENT THE PROCESS AND SLOW NEURODEGENERATION. TOWARDS THIS GOAL, HUAXI XU'S RESEARCH GROUP INVESTIGATED A POTENTIAL NEW PLAYER, SUGGESTED BY LINKAGE OF A PSP-ASSOCIATED GENE VARIANT WITH EXPRESSION OF THE PROTEIN APPOPTOSIN. IN RESEARCH PUBLISHED IN NEURON, THEY EXAMINED LEVELS OF APPOPTOSIN IN PSP AND ALZHEIMER'S PATIENTS' BRAINS AND FOUND THAT THEY WERE INCREASED, AND THEN LOOKED AT THE EFFECTS OF HIGH LEVELS OF APPOPTOSIN IN NEURONS. THE SCIENTISTS OBSERVED INCREASED TAU CLEAVAGE, KNOWN TO PROMOTE AGGREGATION INTO TANGLES, INDICATING THAT THE PROTEIN DIRECTLY CONTRIBUTES TO THE DISEASE PROCESS. THUS, APPOPTOSIN AND CASPASE-3, THE ENZYME RESPONSIBLE FOR CLEAVING TAU, MAY BE POTENTIAL TARGETS FOR NEW DRUGS TO TREAT THESE DISEASES. NEWLY IDENTIFIED CAUSE OF MOTOR NEURON DISEASE PAVES WAY FOR BETTER TREATMENTS. IN MOTOR NEURON DISEASES, A CLASS OF DISEASES INCLUDING AMYOTROPHIC LATERAL SCLEROSIS (ALS), THE NERVE CELLS THAT CONTROL MUSCLE MOVEMENTS GRADUALLY DIE OFF, CAUSING A LOSS OF MUSCLE CONTROL AND EVENTUALLY DEATH. THESE NERVE CELLS (CALLED MOTOR NEURONS) ARE HIGHLY ACTIVE, SO THEY PRODUCE A LOT OF PROTEIN, PUTTING STRESS ON THE CELL COMPARTMENT THAT PROCESSES PROTEINS INTO THEIR FINAL FORM, THE ENDOPLASMIC RETICULUM (ER). DRUGS THAT HELP COUNTERACT STRESS ON THE ER EXTEND THE LIVES OF MICE WITH MOTOR NEURON DISEASE, SUGGESTING THIS MAY BE A USEFUL STRATEGY FOR TREATING SUCH DISEASES IN HUMANS. IN A PAPER IN ELIFE, DONGXIAN ZHANG'S RESEARCH GROUP IDENTIFIED A NEW PROTEIN, MEMBRALIN, THAT APPEARS NECESSARY FOR A HEALTHY ENDOPLASMIC RETICULUM. MICE THAT LACK THE GENE FOR MEMBRALIN DIE WITHIN FIVE OR SIX DAYS AFTER BIRTH BECAUSE THEIR MOTOR NEURONS DIE OFF. FURTHER EXAMINATION OF HOW MEMBRALIN PROMOTES HEALTHY ER FUNCTION AND PROTECTS AGAINST MOTOR NEURON DEATH SHOULD IDENTIFY NOVEL DRUG TARGETS THAT COULD IMPROVE CLINICAL OUTCOMES FOR PATIENTS SUFFERING FROM SEVERE, EARLY-ONSET MOTOR NEURON DISORDERS. IMMUNITY & PATHOGENESIS RESEARCHERS REAWAKEN SLEEPING HIV IN PATIENT CELLS TO ELIMINATE THE VIRUS. ANTIRETROVIRAL THERAPIES (ART) HAVE MADE IT POSSIBLE FOR PEOPLE TO LIVE WITH AIDS FOR DECADES. HOWEVER, HIV'S GENES REMAIN IN SMALL RESERVOIRS OF A PATIENT'S CELLS. THIS MEANS PATIENTS CAN'T STOP TAKING ART, BECAUSE RE-ACTIVATION OF THESE DORMANT GENES IN THEIR ABSENCE WOULD ALLOW THE VIRUS TO REBOUND. THERAPIES THAT WOULD REACTIVATE THOSE GENES WHILE PATIENTS CONTINUE TO TAKE ART WOULD ELIMINATE ALL OF THE VIRUS'S GENES AND ARE THUS HIGHLY SOUGHT AFTER. THE APPROACH HAS REMAINED ELUSIVE SO FAR, BECAUSE DRUGS THAT REAWAKEN THE VIRUS COULD ALSO TRIGGER MASSIVE IMMUNE SYSTEM ACTIVATION, WHICH ITSELF COULD BE DEADLY. TOWARDS THIS GOAL, SUMIT CHANDA'S LAB LOOKED FOR GENES THAT KEEP THE VIRUS SILENT BY INDIVIDUALLY INACTIVATING THEM. ONE OF THE MOST IMPORTANT SILENCERS THEY IDENTIFIED, IN A PUBLICATION IN CELL HOST MICROBE, IS INHIBITED BY A CLASS OF DRUGS CALLED SMAC MIMETICS. TREATING HIV-INFECTED T CELLS WITH THESE DRUGS (IN COMBINATION WITH ANOTHER COMPOUND REQUIRED TO DE-SIL
FORM 990, PART VI, LINE 4	SIGNIFICANT CHANGES TO GOVERNING DOCUMENTS THE ORGANIZATION CHANGED IT'S NAME FROM SANFORD BURNHAM MEDICAL RESEARCH INSTITUTE TO SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE ON JUNE 24, 2015. FORM 990, PART VI, LINE 11B PROCESS USED BY MANAGEMENT AND/OR GOVERNING BODY TO REVIEW FORM 990 THE 990 IS PREPARED BY THE FINANCE DEPARTMENT. IT IS REVIEWED BY THE INSTITUTE'S TAX ADVISORS, SELECTED MEMBERS OF MANAGEMENT INCLUDING THE CHIEF FINANCIAL OFFICER AND THE AUDIT COMMITTEE OF THE BOARD OF TRUSTEES AND PROVIDED TO MEMBERS OF THE BOARD PRIOR TO FILING.
FORM 990, PART VI, LINE 12C	DESCRIPTION OF PROCESS TO MONITOR TRANSACTIONS FOR CONFLICT OF INTEREST CONFLICT OF INTEREST STATEMENTS ARE GIVEN TO MANAGEMENT STAFF AND PRINCIPAL INVESTIGATORS ON A PERIODIC BASIS TO REPORT ON CONFLICTS OR LACK OF CONFLICTS. THE STATEMENTS ARE REVIEWED ANNUALLY BY THE SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, WITH A SUMMARY OF THE REVIEW PROVIDED TO THE CFO. AN ASSESSMENT IS MADE AS TO WHETHER A CONFLICT CAN BE MANAGED BY THE EXISTING DEPARTMENTS AND PRACTICES. CONFLICTS ARE BROUGHT TO THE BOARD OF TRUSTEES ON AN AS NEEDED BASIS. CONFLICTS AND POTENTIAL CONFLICTS THAT INVOLVE THE CEO OR THE PRESIDENT ARE BROUGHT TO THE BOARD OF TRUSTEES TO ADDRESS ANY ACTUAL OR POTENTIAL POSSIBILITY THAT THE DESIGNATED REVIEWERS (I.E., SENIOR DIRECTOR, INTELLECTUAL PROPERTY AND THE SENIOR DIRECTOR, SPONSORED RESEARCH, AND THE CFO) COULD BE PRESSURED TO MAKE BIASED DECISIONS IN MANAGING CONFLICTS INVOLVING THE CEO OR PRESIDENT. AS TO RESTRICTIONS IMPOSED: THE INSTITUTE WILL EMPLOY THE MECHANISM THAT IS THE BEST FIT WITH THE FACTS AND CIRCUMSTANCES OF ANY IDENTIFIED CONFLICT OF INTEREST. METHODS TO MANAGE POTENTIAL CONFLICTS/ENFORCEMENT MECHANISM: REVIEWING MANAGEMENT IS RESPONSIBLE FOR MANAGING, REDUCING, OR ELIMINATING REAL OR POTENTIAL CONFLICTS OF INTEREST. EXAMPLES OF CONDITIONS OR RESTRICTIONS THAT MIGHT BE IMPOSED TO MANAGE, REDUCE, OR ELIMINATE CONFLICTS OF INTERESTS INCLUDE: -PUBLIC DISCLOSURE OF SIGNIFICANT FINANCIAL INTERESTS -MONITORING OF RESEARCH BY INDEPENDENT REVIEWERS -MODIFICATION OF THE RESEARCH PLAN -DISQUALIFICATION FROM PARTICIPATION IN THE PORTION OF FUNDED RESEARCH THAT COULD BE AFFECTED BY SIGNIFICANT FINANCIAL INTEREST -DIVESTITURE OF SIGNIFICANT FINANCIAL INTERESTS -SEVERANCE OF RELATIONSHIPS THAT CREATE ACTUAL OR POTENTIAL CONFLICTS -REVIEW OF COMMERCIAL SPONSORED RESEARCH AGREEMENTS FOR SCIENTIFIC MERIT BY THE PROGRAM PLANNING COMMITTEE -REMOVAL OF AN AFFECTED PARTY FROM NEGOTIATION WITH A COMPANY WITH WHICH HE/SHE HAS SIGNIFICANT FINANCIAL INTEREST
FORM 990, PART VI, LINES 15A AND 15B	PROCESS FOR DETERMINING COMPENSATION COMPENSATION FOR THE CEO, THE PRESIDENT, THE EXECUTIVE VICE PRESIDENT/CHIEF FINANCIAL OFFICER/CHIEF ADMINISTRATIVE OFFICER, AND OTHER KEY EMPLOYEES IS ESTABLISHED ACCORDING TO INSTITUTE POLICIES WHICH ARE DESIGNED TO MEET THE IRS STANDARD FOR "REBUTTABLE PRESUMPTION OF REASONABLENESS" THE COMPENSATION COMMITTEE OF THE BOARD OF TRUSTEES, CONSISTING OF THREE INDEPENDENT TRUSTEES, REVIEWS COMPARABILITY DATA PROVIDED BY AN INDEPENDENT EXTERNAL CONSULTANT THAT INCORPORATES AND EVALUATES INSTITUTE DATA AND THAT OF COMPARABLE ORGANIZATIONS AND MARKETS FROM WHICH THE INSTITUTE DRAWS ITS EXECUTIVE TALENT. UTILIZING THIS STUDY WHICH INCLUDES THE CONSULTANT'S OPINION ON THE "REASONABLENESS" OF THE PROPOSED COMPENSATION, THE COMPENSATION COMMITTEE, WHICH TYPICALLY SEEKS TO ESTABLISH COMPENSATION BETWEEN THE 50TH AND THE 75TH PERCENTILE OF THE COMPARABILITY DATA, MAKES A DETERMINATION WHETHER THE PROPOSED COMPENSATION IS REASONABLE. IF THE PROPOSAL IS DEEMED TO BE REASONABLE, THE COMPENSATION COMMITTEE CONTEMPORANEOUSLY AND ADEQUATELY DOCUMENTS THE BASIS FOR ITS DETERMINATION AND THEN MAKES A RECOMMENDATION TO THE EXECUTIVE COMMITTEE. IF THE PROPOSAL IS DEEMED REASONABLE BY THE EXECUTIVE COMMITTEE, THE COMPENSATION COMMITTEE PRESENTS ITS FINDINGS AND RECOMMENDATIONS TO THE BOARD OF TRUSTEES IN EXECUTIVE SESSION. IF APPROVED BY THE BOARD OF TRUSTEES, THE PROPOSAL IS THEN IMPLEMENTED AND SUCH DOCUMENTATION IS KEPT IN THE WRITTEN OR ELECTRONIC RECORDS OF THE BOARD OF TRUSTEES. THE PROCESS WAS LAST COMPLETED ON MAY 27, 2015 FOR THE FOLLOWING POSITIONS: 1) CEO 2) PRESIDENT 3) EXECUTIVE VICE PRESIDENT/CAO/CFO/TREASURER 4) SVP EXTERNAL RELATIONS 5) SVP DRUG DISCOVERY & DEVELOPMENT 6) SCIENTIFIC DIRECTOR/PROFESSOR 7) NEUROSCIENCE & AGING AND STEM CELL RESEARCH CENTER DIRECTOR/PROFESSOR 8) CENTER DIRECTOR, LA JOLLA PROFESSOR 9) INFECTIOUS & INFLAMMATORY DISEASE CENTER DIRECTOR/PROFESSOR
FORM 990, PART VI, LINE 19	PROCESS FOR MAKING DOCUMENTS AVAILABLE TO THE PUBLIC DOCUMENTS ARE AVAILABLE UPON REQUEST.
FORM 990, PART XI, LINE 9	UNREALIZED LOSS ON SWAP - ($26,659) ROUNDING - $2 -------------------------- TOTAL - ($26,657)